Details of the Drug Reposition

General Information of This Drug (ID: DMIBFVF)

Drug Name
Nirsevimab   DMIBFVF
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lower respiratory tract infection DISUKK0U CA45 Approved [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Respiratory syncytial virus infection DIS7FWHY 1C80 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761328
2 ClinicalTrials.gov (NCT04484935) Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children. U.S. National Institutes of Health.